SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-021493
Filing Date
2024-04-23
Accepted
2024-04-23 21:00:58
Documents
1
Period of Report
2024-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3169
  Complete submission text file 0001140361-24-021493.txt   4614
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEUROPACE INC 455 N BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address
Kumar Rakhi (Reporting) CIK: 0001856296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 24866521